| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.220 | None | 0.667 | 3 | 0 | 2007 | 2014 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily C member 11 | 0.565 | 0.769 | 4.0E-46 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATP binding cassette subfamily G member 8 | 0.573 | 0.538 | 2.4E-20 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2019 | |||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetyl-CoA carboxylase beta | 0.644 | 0.654 | 7.6E-47 |
|
group | 0.040 | None | 1.000 | 4 | 1 | 2010 | 2015 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.400 | None | 0.908 | 142 | 6 | 1994 | 2020 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2018 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
group | 0.030 | None | 0.333 | 3 | 0 | 2002 | 2019 | ||||||||
|
acyl-CoA synthetase long chain family member 1 | 0.617 | 0.577 | 1.5E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2005 | 2018 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2000 | 2019 | ||||||||
|
Alzheimer disease 17 | 0.839 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
adenosine deaminase 2 | 0.545 | 0.846 | 8.1E-08 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2019 | ||||||||
|
ADAM metallopeptidase domain 19 | 0.659 | 0.538 | 6.8E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2006 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |